terazosin

Generic: terazosin hydrochloride

Labeler: coupler llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin hydrochloride
Labeler coupler llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 5 mg/1

Manufacturer
Coupler LLC

Identifiers & Regulatory

Product NDC 67046-1622
Product ID 67046-1622_4614e8cc-c8ea-4c0f-e063-6394a90a8501
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075317
Listing Expiration 2026-12-31
Marketing Start 2025-12-16

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 670461622
Hyphenated Format 67046-1622

Supplemental Identifiers

RxCUI
313219
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA075317 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BLISTER PACK (67046-1622-3)
source: ndc

Packages (1)

67046-1622-3 30 CAPSULE in 1 BLISTER PACK (67046-1622-3)

Ingredients (1)

terazosin hydrochloride (5 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4614e8cc-c8ea-4c0f-e063-6394a90a8501", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313219"], "spl_set_id": ["4614e8cc-c922-4c0f-e063-6394a90a8501"], "manufacturer_name": ["Coupler LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BLISTER PACK (67046-1622-3)", "package_ndc": "67046-1622-3", "marketing_start_date": "20251216"}], "brand_name": "Terazosin", "product_id": "67046-1622_4614e8cc-c8ea-4c0f-e063-6394a90a8501", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "67046-1622", "generic_name": "Terazosin Hydrochloride", "labeler_name": "Coupler LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20251216", "listing_expiration_date": "20261231"}